Efficacy of multidrug therapy combined with mizoribine in children with diffuse IgA nephropathy in comparison with multidrug therapy without mizoribine and with methylprednisolone pulse therapy

American Journal of Nephrology

Volumn 24, Issue 6, 2004, Pages 576-581

  Kawasaki, Yukihiko ^a   Hosoya, Mitsuaki ^a   Suzuki, Junzo ^a   Onishi, Noriko ^a   Takahashi, Ai ^a   Isome, Masato ^a   Nozawa, Ruriko ^a   Suzuki, Hitoshi ^a  

^a FUKUSHIMA UNIVERSITY   (Japan)

Author keywords

Diffuse iga nephropathy; Iga nephropathy; Methylprednisolone; Mizoribine; Multidrug therapy; Prednisolone

Indexed keywords

DIPYRIDAMOLE; METHYLPREDNISOLONE; MIZORIBINE; PREDNISOLONE; WARFARIN;

ADOLESCENT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SCREENING; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INFORMATION PROCESSING; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PULSATILE DRUG RELEASE; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; BIOPSY; CHILD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; METHYLPREDNISOLONE; PULSE THERAPY, DRUG; RETROSPECTIVE STUDIES; RIBONUCLEOSIDES;

EID: 13244288684     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082202     Document Type: Article

References (28)

1. Berger J, Hinglais N: Les dépôts intercapillaires d'IgA-IgG. J Urol Néphrol 1968;74:694-695.
2. Droz D: Natural history of primary glomerulonephritis with mesangial deposits of IgA; in Sterzel RB, Thomson D, Brod J (eds): Glomerulonephritis. Contrib Nephrol. Basel Karger, 1976, vol 2, pp 150-157.
3. Chida Y, Tomura S, Takeuchi J: Renal survival rate of IgA nephropathy. Nephron 1985;40:189-194.
4. Southwest Pediatric Nephrology Study Group: A multicenter study of IgA nephropathy in children. Kidney Int 1982;22:643-652.
5. McEnery PT, McAdams AJ, West CD: Glomerular morphology, natural history and treatment of children with IgA-IgG mesangial nephropathy; in Kincaid-Smith P, Mathew TH, Becker EL (eds): Glomerulonephritis: Natural History and Treatment. New York, Wiley, 1972, pp 305-320.
6. Andreoli SP, Bergstein JM: Treatment of severe IgA nephropathy in children. Pediatr Nephrol 1989;3:248-253.
7. Yoshimura M, Kida H, Saito Y, et al: Effects of methylprednisolone pulse therapy on progressive IgA nephropathy. Nippon Jinzo Gakkai Shi 1991;33:761-768.
8. Woo KT, Lee GS, Lim CH, et al: Effects of triple therapy in IgA nephritis: A follow-up study 5 years later. Clin Nephrol 1991;36:60-66.
9. Welch TR, Fryer C, Quinlan M, et al: Doubleblind, controlled trial of short-term prednisone therapy in immunoglobulin A glomerulonephritis. J Pediatr 1992;121:474-477.
10. Murakami K, Yoshioka K, Maki S, et al: Combined therapy in children and adolescents with IgA nephropathy. Nippon Jinzo Gakkai Shi 1994;36:38-43.
11. Goumenos D, Ahuja M, Shortland JR, et al: Can immunosuppressive drugs slow the progression of IgA nephropathy? Nephrol Dial Transplant 1995;10:1173-1181.
12. Kobayashi Y, Hiki Y, Tateno S, et al: Steroid therapy during the early stage of progressive IgA nephropathy: A 10-year follow-up study. Nephron 1996;72:237-242.
13. Yoshikawa N, Ito H, Ninomiya M, The Japanese Pediatric IgA Nephropathy Treatment Study Group: A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. J Am Soc Nephrol 1999;10:101-109.
14. Mizuno K, Tsujino M, Takada M, et al: Studies on bredinin. I. Isolation, characterization and biological properties. J Antibiot (Tokyo) 1974;27:775-782.
15. Hughes SE, Gruber SA: New immunosuppressive drugs in organ transplantation. J Clin Pharmacol 1996;36:1081-1092.
16. Ishikawa H: Mizoribine and mycophenolate mofetil. Curr Med Chem 1999;6:575-597.
17. Inoue T, Kusaba R, Otsubo O, et al: Clinical trial of bredinin in renal transplantation. Transplant Proc 1981;13:315-318.
18. Kaneko K, Nagaoka R, Ohtomo Y, et al: Mizoribine for childhood IgA nephropathy. Nephron 1999;83:376-377.
19. Nagaoka R, Kaneko K, Ohtomo Y, et al: Mizoribine treatment for childhood IgA nephropathy. Pediatr Int 2002;44:217-223.
20. Churg J, Bernstein J, Glassock RJ: Classification and Atlas of Glomerular Diseases, ed 2. Tokyo, Igaku Shoin, 1995, pp 86-88.
21. Yoshikawa N, Ito H, Nakamura H: Prognostic factors in childhood IgA nephropathy. Nephron 1992;60:60-67.
22. Welch TR, Fryer C, Shely E, et al: Doubleblind, controlled trial of short-term prednisone therapy in immunoglobulin A glomerulonephritis J Pediatr 1992;121:474-477.
23. Waldo FB, Alexander R, Wyatt RJ, et al: Alternate-day prednisone therapy in children with IgA-associated nephritis. Am J Kidney Dis 1989;13:55-60.
24. Watanabe T, Takahashi S, Nakajo S, et al: Pathological improvement of IgA nephropathy and Henoch-Schönlein purpura nephritis with urokinase therapy. Acta Paediatr Jpn 1996;38:622-628.
25. Kawasaki Y, Suzuki J, Nozawa R, et al: Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis. Pediatrics 2003; 111(4 Pt 1):785-789.
26. White RH: Henoch-Schönlein nephritis: A disease with signifi cant late sequelae. Nephron 1994;68:1-9.
27. Szer IS: Henoch-Schönlein purpura: When and how to treat. J Rheumatol 1996;23:1661-1665.
28. Yoshioka K, Ohashi Y, Sakai T, et al: A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Kidney Int 2000;58:317-324.